Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of isavuconazole in invasive cerebral aspergillosis during hematopoietic stem cell transplantation in a pediatric patient with myelodysplastic syndrome: A case report.
Nemoto H, Hino M, Aoki T, Yamashita Y, Okunushi T, Nagasawa K, Ishiwada N, Watanabe A, Yamazaki S, Hamada H. Nemoto H, et al. Among authors: aoki t. J Infect Chemother. 2025 Jan;31(1):102478. doi: 10.1016/j.jiac.2024.07.018. Epub 2024 Jul 22. J Infect Chemother. 2025. PMID: 39047812
Erythematous Plaques in a Child with Sweet Syndrome.
Aoki T, Yamashita Y, Minamitani K, Ota S, Hayakawa K. Aoki T, et al. J Pediatr. 2016 Sep;176:210-210.e1. doi: 10.1016/j.jpeds.2016.05.055. Epub 2016 Jun 16. J Pediatr. 2016. PMID: 27318383 No abstract available.
Low Frequency of Programmed Death Ligand 1 Expression in Pediatric Cancers.
Aoki T, Hino M, Koh K, Kyushiki M, Kishimoto H, Arakawa Y, Hanada R, Kawashima H, Kurihara J, Shimojo N, Motohashi S. Aoki T, et al. Pediatr Blood Cancer. 2016 Aug;63(8):1461-4. doi: 10.1002/pbc.26018. Epub 2016 May 2. Pediatr Blood Cancer. 2016. PMID: 27135656 Free PMC article.
Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.
Aoki T, Koh K, Ikeda Y, Sekinaka Y, Akiyama K, Mori M, Arakawa Y, Hanada R. Aoki T, et al. Biol Blood Marrow Transplant. 2016 Sep;22(9):1725-1728. doi: 10.1016/j.bbmt.2016.05.021. Epub 2016 May 28. Biol Blood Marrow Transplant. 2016. PMID: 27246371 Free article.
A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20).
Tomizawa D, Tsujimoto SI, Tanaka S, Matsubayashi J, Aoki T, Iwamoto S, Hasegawa D, Nagai K, Nakashima K, Kawaguchi K, Deguchi T, Kiyokawa N, Ohki K, Hiramatsu H, Shiba N, Terui K, Saito AM, Kato M, Taga T, Koshinaga T, Adachi S. Tomizawa D, et al. Among authors: aoki t. Jpn J Clin Oncol. 2022 Oct 6;52(10):1225-1231. doi: 10.1093/jjco/hyac105. Jpn J Clin Oncol. 2022. PMID: 35809896 Clinical Trial.
4,503 results